Pfizer Inc.

    2021 2020 2019 2018 2017
Revenue $81.29B$41.91B$51.75B$53.65B$52.55B
Cost of Revenue $30.82B$8.69B$10.22B$11.25B$11.24B
Gross Profit $50.47B$33.22B$41.53B$42.4B$41.31B
Gross Profit Margin 62.08%79.26%80.25%79.03%78.61%
Operating Expenses $30.23B$24.46B$27.61B$27.35B$27.2B
Research & Development Expenses (R&D) $13.83B$9.4B$8.65B$8.01B$7.66B
Selling, General & Administrative Expenses (SG&A) $12.7B$11.62B$14.35B$14.46B$14.78B
Other Expenses $3.7B$3.44B$4.61B$4.89B$4.76B
Net Income $21.98B$9.62B$16.27B$11.15B$21.31B
Net Profit Margin 27.04%22.95%31.45%20.79%40.55%
Operating Income $20.23B$8.76B$13.92B$15.04B$14.11B
Other Income & Expenses (Net) $4.08B$-1.26B$3.76B$-3.16B$-1.8B
Depreciation & Amortization $5.19B$4.78B$6.01B$6.38B$6.27B
Interest Income $36M$73M$226M$333M$391M
Interest Expense $1.29B$1.45B$1.57B$1.32B$1.27B
Income Tax Expense $1.85B$477M$1.38B$706M$-9.05B
Effective Tax Rate 7.62%6.36%7.83%5.94%-73.54%
EBITDA $30.31B$16.32B$25.24B$19.56B$19.8B
EBIT $25.12B$11.54B$19.23B$13.18B$13.53B
EBT N/AN/AN/AN/AN/A
Shares Outstanding 5.6B5.55B5.57B5.87B5.97B
Diluted Shares Outstanding 5.71B5.63B5.67B5.98B6.06B
EPS $3.92$1.73$2.92$1.9$3.57
Diluted EPS $3.85$1.71$2.87$1.87$3.52

Copyright © 2022 STOCKROUTINES